Suppr超能文献

韩国腹膜透析患者的细胞外液容量扩张与残余肾功能的保留:一项长期随访研究。

Extracellular volume expansion and the preservation of residual renal function in Korean peritoneal dialysis patients: a long-term follow up study.

作者信息

Rhee Harin, Baek Min Ja, Chung Hyun Chul, Park Jong Man, Jung Woo Jin, Park Soo Min, Lee Jang Won, Shin Min Ji, Kim Il Young, Song Sang Heon, Lee Dong Won, Lee Soo Bong, Kwak Ihm Soo, Seong Eun Young

机构信息

Department of Internal Medicine, Pusan National University School of Medicine, Pusan, South Korea.

Division of Nephrology, Biomedical Research Institute, Pusan National University Hospital, Gudeok-ro179, Seo-gu, Pusan, 602-739, South Korea.

出版信息

Clin Exp Nephrol. 2016 Oct;20(5):778-786. doi: 10.1007/s10157-015-1203-2. Epub 2015 Nov 26.

Abstract

INTRODUCTION

In chronic peritoneal dialysis patients, preservation of residual renal function (RRF) is a major determinant of patient survival, and maintaining sufficient intravascular volume has been hypothesized to be beneficial for the preservation of RRF. The present study aimed to test this hypothesis using multifrequency bioimpedence analyzer (MFBIA), in Korean peritoneal dialysis patients.

METHODS

A total of 129 patients were enrolled in this study. The baseline MFBIA was checked, and the patients were divided into the following two groups: group 1, extracellular water per total body water (ECW/TBW) < median, group 2, ECW/TBW > median. We followed up the patients, and then we analyzed the changes in the urine output (UO) and the solute clearance (weekly uKt/V) in each group. Data associated with patient and technical survivor were collected by medical chart review. The volume measurement was made using Inbody S20 equipment (Biospace, Seoul, Korea). We excluded the anuric patients at baseline.

RESULT

The median value of ECW/TBW was 0.396. The mean patient age was 49.74 ± 10.01 years, and 62.1 % of the patients were male; most of the patients were on continuous ambulatory peritoneal dialysis (89.1 %). The mean dialysis vintage was 26.20 ± 28.71 months. All of the patients were prescribed hypertensive medication, and 48.5 % of the patients had diabetes. After 25.47 ± 6.86 months of follow up, ΔUO and Δweekly Kt/V were not significantly different in the two groups as follows: ΔUO (-236.07 ± 185.15 in group 1 vs -212.21 ± 381.14 in group 2, p = 0.756); Δ weekly Kt/v (-0.23 ± 0.43 in group 1 vs -0.29 ± 0.49 in group 2, p = 0.461). The patient and technical survivor rate was inferior in the group 2, and in the multivariable analysis, initial hypervolemia was an independent factor that predicts both of the patient mortality [HR 1.001 (1.001-1.086), p = 0.047] and the technical failure [HR 1.024 (1.001-1.048), p = 0.042].

CONCLUSIONS

Extracellular volume expansion, measured by MFBIA, does not help preserve residual renal function, and is harmful for the technical and patient survival in Korean peritoneal dialysis patients.

摘要

引言

在慢性腹膜透析患者中,残余肾功能(RRF)的保留是患者生存的主要决定因素,并且维持充足的血管内容量被认为有利于RRF的保留。本研究旨在使用多频生物电阻抗分析仪(MFBIA)对韩国腹膜透析患者验证这一假设。

方法

本研究共纳入129例患者。检查基线MFBIA,并将患者分为以下两组:第1组,细胞外液占总体液比例(ECW/TBW)<中位数;第2组,ECW/TBW>中位数。对患者进行随访,然后分析每组患者尿量(UO)和溶质清除率(每周uKt/V)的变化。通过病历审查收集与患者和技术生存相关的数据。使用Inbody S20设备(韩国首尔百利达公司)进行容量测量。我们排除了基线时无尿的患者。

结果

ECW/TBW的中位数为0.396。患者平均年龄为49.74±10.01岁,62.1%的患者为男性;大多数患者接受持续非卧床腹膜透析(89.1%)。平均透析龄为26.20±28.71个月。所有患者均服用抗高血压药物,48.5%的患者患有糖尿病。经过25.47±6.86个月的随访,两组的ΔUO和Δ每周Kt/V无显著差异,如下所示:ΔUO(第1组为-236.07±185.15,第2组为-212.21±381.14,p=0.756);Δ每周Kt/v(第1组为-0.23±0.43,第2组为-0.29±0.49,p=0.461)。第2组的患者和技术生存率较低,在多变量分析中,初始高血容量是预测患者死亡率[风险比1.001(1.001-1.086),p=0.047]和技术失败[风险比1.024(1.001-1.048),p=0.042]的独立因素。

结论

通过MFBIA测量的细胞外液容量扩张无助于保留残余肾功能,并且对韩国腹膜透析患者的技术和患者生存有害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验